Skip to main content
Publications
Toplak H, Bilitou A, Alber H, Auer J, Clodi M, Ebenbichler C, FlieBer-Gorzer E, Gelsinger C, Hanusch U, Ludvik B, Maca T, Schober A, Sock R, Speidl WS, Stulnig TM, Weitgasser R, Zirlik A, Koch M, Wienerroither S, Wolowacz SE , Diamand F, Catapano AL. Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients . Wein Klin Wochenschr. 2023 Jul;135(13-14):364-74. doi: 10.1007/s00508-023-02221-4
Carrasquilla G, Porras A, Martinez S, DeAntonio R, Devadiga R, Talarico C, Caceres D, Juliao P . Pneumococcal disease mortality in children<5 years of age after pneumococcal conjugate vaccine introduction in Colombia: a time-trend analysis, 2005-2016 . Poster presented at the 18th International Congress on Infectious Diseases (ICID); March 1, 2018. Buenos Aires, Argentina. [abstract] International journal of infectious diseases and therapy. 2018 Aug; 73(Supplement). doi: 10.1016/j.ijid.2018.04.3922
Samelson EJ, Miller PD, Christiansen C, Daizedeh NS, Grazette L, Anthony MS , Egbuna O, Wang A, Siddhanti SR, Cheung AM, Franchimont N, Kiel DP. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk . J Bone Miner Res. 2014 Feb;29(2):450-7. doi: 10.1002/jbmr.2043